iPro2 Professional CGM

iPro2 Professional CGM

 

Gain better diabetes insights with iPro2 CGM for type 2 patients like Bernard.


Placed on the patient’s abdomen, the iPro™2 recorder and Enlite sensor are worn for up to six days.

UNCOVER MORE
IN LESS TIME1

iPro™2 Professional Continuous Glucose Monitoring (CGM)


An iPro2 evaluation reveals glucose fluctuations that A1C tests and fingersticks can miss. When used to tailor treatment recommendations for patients, iPro2 professional CGM data can lead to better glucose control.2

  • Small, discreet, comfortable and watertight3
  • Masked data to maintain regular behavior
  • Patient set-up in minutes
  • Personalized reports linked to lifestyle behaviors for added context

Want to know more? We’ll give you a call!


For more product information or to place an order:
Call 1-877-874-7717 (M-F 10AM-6PM CT)
Email ipro2@medtronic.com

1. Mohan Study (2015) Presented in part at ATTD Paris 2015
2. Tanenberg R, et al. Use of the continuous glucose monitoring system to guide therapy in patients with insulin- treated diabetes. Mayo Clin Proc. 2004; 17: 1521-1526.
3. When used with Enlite® glucose sensor. The iPro2 and sensor are watertight for up to 30 minutes, up to a depth of 8 feet (2.4 meters). There is no time limit for swimming on the surface of the water or showering.
4. Kaufman FR, et al. Diabetes Care. 2001;24(12):2030−2034.


New CareLink® iPro® Pattern Snapshot Report

Easily interpret patient CGM data with the simple CareLink™ iPro Pattern Snapshot report.


iPro2 Professional
Assess results quickly
  • Simple visuals
  • Most important metrics — all on one page1
Identify priority issues
  • Top three issues prioritized
  • Visuals of meal times and daily glucose values
Educate and coach patients
  • Details of each priority issue
  • Possible causes for each pattern

1. Based on market research, qualitative interviews with primary care physicians and endocrinologists (April 2015).



New CareLink iPro Pattern Snapshot

iPro2 Professional CGM Sensor Serter

 

Getting to Know the System

Enlite Sensor and Serter
iPro2 CGM components:

  • iPro2 recorder
    • Low profile
    • Multi-patient use
  • Enlite sensor
    • Small and comfortable
    • Thin and flexible - no needle stays in the body
  • Enlite serter
    • Easy insertion for a virtually pain-free experience for your patients1
    • Completely hidden needle
1 U.S. Enlite Clinical Study Customer Satisfaction Survey. Data on file, Medtronic MiniMed, Inc., Northridge, CA.

Introducing the iPro®2 myLog App

 

Introducing the iPro™2 myLog App


An easy and convenient way for patients to log events while on their iPro2 CGM evaluation.

  • Nearly 90% of patients will log more events using the myLog app1
  • myLog improves iPro2 evaluation process:
    • Events automatically sent to CareLink iPro
    • Simultaneously creates patient record in CareLink iPro
    • Easy to read patient notes
  • Actionable reports linking behavior to glucose variability
  • Compatible with Fitbit® trackers

MiniMed myLog App    Download on the App Store   

Medtronic and Fitbit recently announced a partnership to integrate health and activity tracking with the iPro2 Professional CGM system. The iPro2 myLog mobile app is the first data integration effort resulting from this partnership.
To learn more click here.

1. Medtronic Marketing Research; n=109 diabetes patients. Data on File. 09/2016

Fitbit is a registered trademark and service mark for Fitbit, Inc. iPro2 myLog is designed for use with the Fitbit platform. This product is not put out by Fitbit, and Fitbit does not service or warrant the functionality of this product.



iPro2 Professional Giving Back

We are giving back!

 

We’re giving back to celebrate the new myLog app!


2 New myLog users   One tree planted in a local forest

Get your iPro™2 patients to use myLog and save a forest.


*Beginning August 7th we will plant one tree in a local forest for every two new patients who use the myLog app during their iPro2 evaluation.


iPro2 Professional CGM 3


Important Safety Information

Continuous glucose monitoring systems are limited to sale by or on the order of a physician or should only be used under the direction of a healthcare professional familiar with the risks associated with these systems. Continuous glucose monitoring systems are intended for monitoring interstitial glucose levels in persons with diabetes. These systems provide information regarding potential high and low glucose levels and can provide an indication of when patients should obtain a glucose reading using a home glucose reader. The information provided by continuous glucose monitoring systems is intended to supplement, not replace, readings from a home glucose meter. Insertion of a glucose sensor may cause bleeding or irritation at the insertion site. Consult a physician immediately if you experience significant pain or if you suspect that the site is infected.

For additional important safety information, visit MedtronicDiabetes.com/Important-Safety-Information.

By submitting this form, you are granting Medtronic MiniMed, Inc. ("Medtronic") permission to add your contact information to its database for sending you additional information and communications related to Medtronic products and therapies. You may revoke this permission at any time by e-mailing takecontrol@medtronic.com or by sending a request in writing to: Medtronic MiniMed, Inc. c/o Customer Support, 18000 Devonshire Street, Northridge, CA 91325-1219. Medtronic respects and upholds the confidentiality of your personal information. We will not share your personal information with any third-parties, except as otherwise noted in our Website Privacy Policy here: www.medtronicdiabetes.com/privacy-policy